“…Treatment with 1 lM PF, a PYK2 inhibitor, or 3 lM U0126, a MEK/ERK inhibitor, largely prevented Ab 42 -induced microglial activation (Figure 8a,b). As introduced above, it has been welldocumented that TNF-a is potent in inducing neurotoxicity and that Ab-induced generation of TNF-a from microglial cells significantly contributes to neuroinflammation in AD (Alam et al, 2016;Block et al, 2007;Doll et al, 2015;Heppner et al, 2015;Krabbe et al, 2017;Liu & Hong, 2003;Montgomery et al, 2011;Montgomery et al, 2013;Wyss-Coray & Rogers, 2012). Treatment with 1 lM PF or 3 lM U0126 strongly inhibited Ab 42 -induced activation of PARP-1 (Figure 9a It has been well recognized that Ab causes neuroinflammation via inducing microglial activation and generation of excessive proinflammatory cytokines, thereby contributing to AD (Heneka et al, 2015;Heppner et al, 2015).…”